Newzvia

Health | WHO Notes Mpox Drop in West Africa, Watches Asia Resurgence

Pankaj Mukherjee, Senior Technology Correspondent

Pankaj Mukherjee

Senior Technology Correspondent · AI, startups & MeitY policy

2 min read

Quick summary

The World Health Organization announced a significant decrease in mpox transmission rates in West Africa this week. However, the global health body also noted a slight resurgence in isolated urban clusters within Southeast Asia, urging continued vigilance.

The World Health Organization (WHO), a global health body, shared its latest report on how diseases are spreading this week. Good news came from West Africa. The report noted a big drop in mpox cases there.

But there's also a careful watch needed elsewhere. The WHO's update pointed to a small rise in mpox in some city areas of Southeast Asia. This region is close to India.

A Mixed Picture on Mpox

Mpox is a viral disease. It causes rashes and other flu-like symptoms. For a long time, it was mostly seen in parts of Africa. But a global outbreak began in 2022. It spread to many countries.

The WHO's weekly epidemiological update—a regular report tracking disease patterns—showed promising signs. Many nations in West Africa saw fewer new mpox infections. This suggests that public health efforts are working there. These efforts include careful watching for disease, called surveillance, and vaccination drives.

However, the picture is not entirely clear. The health agency is now closely monitoring small clusters of mpox in Southeast Asia. These are isolated urban areas, meaning they are separate outbreaks in cities. The exact reasons for this slight increase are still being studied.

Why Continued Vigilance Matters

This mixed report highlights a key lesson: emerging diseases need constant attention. The WHO stressed the need to keep up surveillance. This means health officials must continue to watch for new cases. They must also trace contacts of infected people. Vaccination against mpox is also still important worldwide.

For India, this global update carries a special weight. With mpox cases appearing in our neighbourhood, staying alert is crucial. Our public health system, including the ICMR (Indian Council of Medical Research), must remain ready. Quick detection and response can stop outbreaks from growing.

This mpox situation reminds us of other health challenges. For instance, the US CDC (Centers for Disease Control and Prevention) recently found a new respiratory illness in Oregon and Washington. Also, the GAVI Alliance, a group that helps fund vaccines, is supporting a new vaccine for a hemorrhagic fever in Central Africa. These events show how important it is to track and fight new diseases everywhere.

Key Takeaways

  • The WHO reports a significant drop in mpox cases across West Africa.
  • Isolated urban clusters in Southeast Asia show a slight mpox resurgence.
  • Continued disease surveillance and vaccination efforts remain crucial globally.

People also ask

What is the WHO update about?
It's about global mpox trends: West Africa drops, Southeast Asia sees minor resurgences.
Is mpox still a concern?
Yes — The WHO urges ongoing surveillance and vaccination. Small outbreaks in new areas confirm it still requires close monitoring.
What does 'surveillance' mean?
Surveillance means carefully watching for disease to track outbreaks quickly.
Why is this important for India?
Given proximity to Southeast Asia, India needs alertness. Tracking nearby mpox prepares its health system.
Newzvia·30 Sept 2026

WHO Warns: Measles Cases Surge in Southeast Asia

The World Health Organization (WHO) today alerted nations to a sharp rise in measles cases across Southeast Asia. This increase comes after breaks in routine child vaccination programmes, highlighting an urgent need to catch up on immunisation.
Read article
Newzvia·27 Sept 2026

WHO Updates Dengue Guidelines as Southeast Asia Sees Case Surge

The World Health Organization (WHO) has issued new recommendations to fight dengue fever as cases climb sharply across Southeast Asia. While focused on the region, these updated guidelines are highly relevant for India, which also battles regular dengue outbreaks.
Read article
Newzvia·25 Sept 2026

US FDA Clears Early Alzheimer's Drug, But Studies Continue

The US drug regulator has given quick approval to a new medicine, Cognitora, for early Alzheimer's disease. While this offers a ray of hope for slowing memory decline, full long-term proof is still needed, with Indian patients watching closely.
Read article
Newzvia·23 Sept 2026

WHO Warns of New RSV Strain Causing Severe Illness in Young Kids

The World Health Organization (WHO) has sounded an alarm about a novel respiratory syncytial virus (RSV) strain, RSV-B.2, now causing severe infections in children under five across Southeast Asia. This new strain is leading to more hospitalizations and putting pressure on local pediatric care systems.
Read article
Newzvia·20 Sept 2026

WHO Alerts on Rising Tick-Borne CCHF in East Africa

The World Health Organization (WHO) has issued an urgent alert about a rise in Crimean-Congo Hemorrhagic Fever (CCHF) cases across several East African nations, mainly Uganda and Kenya. This tick-borne illness needs careful monitoring, and India, which has faced CCHF before, can learn from global responses to such outbreaks.
Read article
Newzvia·18 Sept 2026

WHO Tags New RSV Strain 'Variant of Concern' Amid Global Rise

The World Health Organization (WHO) has named a new strain of Respiratory Syncytial Virus (RSV-V.26) a 'Variant of Concern' after a quick rise in global infections. This tag means health bodies worldwide are now watching the virus very closely and speeding up research.
Read article

More from categories

Business

View all

Technology

View all

Sports

View all